Management of open-angle glaucoma after the LIGHT trial: what is the role of hospital optometri...

26 November 2019
Volume 20, Issue 4
Glaucoma

This article outlines the laser treatment modalities for glaucoma and ocular hypertension.

Glaucoma, including primary open-angle glaucoma, is a leading cause of visual loss in the UK and around the world. Considered in the context of the optometrist’s role in glaucoma care, this article outlines the laser techniques used to treat the condition, together with the results of a new treatment study, the Laser in Glaucoma and Ocular Hypertension (LiGHT) trial.

Sign in to continue

Forgotten password?
Register

Sign in to view the article

Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Join the College today

Related further reading

News in numbers - spring 2025

The clinical figures that count.

AMD Glaucoma Public health Research

Tech news - spring 2025

A glance at what’s happening in the world of technology.

AMD AI and technology Glaucoma Low vision Public health Research

Patient attendance and health-seeking behaviour

Factors influencing people’s health-seeking behaviour could be preventing them from visiting optometry practices and may be putting them at risk of health dangers. To mitigate this, optometrists can take practical steps to attract new patients and encourage more frequent visits, reports Kathy Oxtoby.

Glaucoma Public health